Davide F. Robbiani

Università del Salento

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (12)

Vignesh Shanmugam

Associate Pathologist

Brigham and Women's Hospital

UNITED STATES

View details

Zijun Wang

Rockefeller University

UNITED STATES

View details

Martin Palus

National Veterinary Research Institute

CZECH REPUBLIC

View details

Vaclav Honig

National Veterinary Research Institute

CZECH REPUBLIC

View details

Onur Boyman

University Hospital of Zurich

SWITZERLAND

View details

Fausto Baldanti

ITALY

View details

Jennifer Keeffe

California Institute of Technology

UNITED STATES

View details

Pavel Svoboda

Masaryk University

CZECH REPUBLIC

View details

Julio Cesar Cetrulo Lorenzi

UNITED STATES

View details

qiang pan-hammarstrom

Karolinska University Hospital

SWEDEN

View details

Franca Barbic

Humanitas University

ITALY

View details

Harold Marcotte

Associate Professor

Karolinska Institutet-Huddinge Campus

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Davide F. Robbiani

Research Interests

Explore related searches

Contact this professor

Articles (10)

Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein

Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course.

Enhanced SARS-CoV-2 neutralization by dimeric IgA

Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from disease

Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice

Evolution of antibody immunity to SARS-CoV-2

Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo

A dark side to NS1 antibodies?

Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.

miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms.

Collaborators (12)

Vignesh Shanmugam

Zijun Wang

Martin Palus

Vaclav Honig

Onur Boyman

Fausto Baldanti

Jennifer Keeffe

Pavel Svoboda

Julio Cesar Cetrulo Lorenzi

qiang pan-hammarstrom

Franca Barbic

Harold Marcotte

Make your next move.